New York Blood Center Enterprise

New York Blood Center (NYBC) is a major non-profit organization that serves as one of the largest independent, community-based blood centers in the United States. The enterprise operates the Lindsley F. Kimball Research Institute (LFKRI), which conducts pioneering research in hematology, infectious diseases, and transfusion medicine. Through its Comprehensive Cell Solutions (CCS) division, NYBC provides CDMO services specializing in the development and manufacturing of cell and gene therapies. The organization is globally recognized for its contributions to blood safety, the development of the Hepatitis B vaccine, and its extensive public cord blood bank. NYBC supports nearly 30 million people through its network of regional blood centers and research collaborations.